Follow
Jeppe Ragnar Andersen
Jeppe Ragnar Andersen
CEO at Nordic Bioscience Clinical Development A/S
Verified email at nordicbioscience.com
Title
Cited by
Cited by
Year
Disease-modifying treatments for osteoarthritis (DMOADs) of the knee and hip: lessons learned from failures and opportunities for the future
MA Karsdal, M Michaelis, C Ladel, AS Siebuhr, AR Bihlet, JR Andersen, ...
Osteoarthritis and Cartilage 24 (12), 2013-2021, 2016
3402016
Effect of Intra-Articular Sprifermin vs Placebo on Femorotibial Joint Cartilage Thickness in Patients With Osteoarthritis: The FORWARD Randomized Clinical Trial
MC Hochberg, A Guermazi, H Guehring, A Aydemir, S Wax, ...
Jama 322 (14), 1360-1370, 2019
2582019
Treatment of symptomatic knee osteoarthritis with oral salmon calcitonin: results from two phase 3 trials
MA Karsdal, I Byrjalsen, P Alexandersen, A Bihlet, JR Andersen, BJ Riis, ...
Osteoarthritis and Cartilage 23 (4), 532-543, 2015
1482015
A randomized, double-blind, multicenter, placebo-controlled study to evaluate the efficacy and safety of oral salmon calcitonin in the treatment of osteoporosis in …
K Henriksen, I Byrjalsen, JR Andersen, AR Bihlet, LA Russo, ...
Bone 91, 122-129, 2016
862016
OA phenotypes, rather than disease stage, drive structural progression–identification of structural progressors from 2 phase III randomized clinical studies with symptomatic …
MA Karsdal, A Bihlet, I Byrjalsen, P Alexandersen, C Ladel, M Michaels, ...
Osteoarthritis and Cartilage 23 (4), 550-558, 2015
742015
Evaluation of the efficacy, safety and pharmacokinetic profile of oral recombinant human parathyroid hormone [rhPTH (1–31) NH 2] in postmenopausal women with osteoporosis
K Henriksen, JR Andersen, BJ Riis, N Mehta, R Tavakkol, P Alexandersen, ...
Bone 53 (1), 160-166, 2013
682013
The impact of clinical trial monitoring approaches on data integrity and cost—a review of current literature
R Olsen, AR Bihlet, F Kalakou, JR Andersen
European journal of clinical pharmacology 72, 399-412, 2016
632016
Impact of source data verification on data quality in clinical trials: an empirical post hoc analysis of three phase 3 randomized clinical trials
JR Andersen, I Byrjalsen, A Bihlet, F Kalakou, HC Hoeck, G Hansen, ...
British journal of clinical pharmacology 79 (4), 660-668, 2015
552015
Long-term structural and symptomatic effects of intra-articular sprifermin in patients with knee osteoarthritis: 5-year results from the FORWARD study
F Eckstein, MC Hochberg, H Guehring, F Moreau, V Ona, AR Bihlet, ...
Annals of the Rheumatic Diseases 80 (8), 1062-1069, 2021
532021
Associations between biomarkers of bone and cartilage turnover, gender, pain categories and radiographic severity in knee osteoarthritis
AR Bihlet, I Byrjalsen, AC Bay-Jensen, JR Andersen, C Christiansen, ...
Arthritis research & therapy 21, 1-10, 2019
422019
Efficacy and safety of intra-articular Sprifermin in symptomatic radiographic knee osteoarthritis: pre-specified analysis of 3-year data from a 5-year randomized, placebo …
M Hochberg, A Guermazi, H Guehring, A Aydemir, S Wax, ...
Osteoarthritis and Cartilage 26, S26-S27, 2018
33*2018
Serum C-reactive protein metabolite (CRPM) is associated with incidence of contralateral knee osteoarthritis
AC Bay-Jensen, A Bihlet, I Byrjalsen, JR Andersen, BJ Riis, ...
Scientific Reports 11 (1), 6583, 2021
232021
Clinical and biochemical factors associated with risk of total joint replacement and radiographic progression in osteoarthritis: Data from two phase III clinical trials
AR Bihlet, JJ Bjerre-Bastos, JR Andersen, I Byrjalsen, MA Karsdal, ...
Seminars in arthritis and rheumatism 50 (6), 1374-1381, 2020
212020
Matrix metalloproteinase mediated type I collagen degradation is an independent predictor of increased risk of acute myocardial infarction in postmenopausal women
DM Bertelsen, JS Neergaard, CL Bager, SH Nielsen, NH Secher, ...
Scientific reports 8 (1), 5371, 2018
212018
Clinical Drug Development Using Dynamic Biomarkers to Enable Personalized Health Care in COPD
AR Bihlet, MA Karsdal, AC Bay-Jensen, S Read, JH Kristensen, ...
CHEST Journal 148 (1), 16-23, 2015
212015
Cohort Profile: The Prospective Epidemiological Risk Factor (PERF) study
JS Neergaard, K Dragsbæk, SN Kehlet, HB Hansen, G Hansen, ...
International Journal of Epidemiology, dyw251, 2016
202016
Does moderate intensity impact exercise and non-impact exercise induce acute changes in collagen biochemical markers related to osteoarthritis?–An exploratory randomized cross …
JJ Bjerre-Bastos, HB Nielsen, JR Andersen, M Karsdal, AC Bay-Jensen, ...
Osteoarthritis and Cartilage 29 (7), 986-994, 2021
152021
OP0059 Efficacy and safety of intra-articular sprifermin in symptomatic radiographic knee osteoarthritis: pre-specified analysis of 3-year data from a 5-year randomised …
M Hochberg, A Guermazi, H Guehring, A Aydemir, S Wax, ...
Annals of the Rheumatic Diseases 77 (Suppl 2), 80-81, 2018
152018
Identification of pain categories associated with change in pain in patients receiving placebo: data from two phase 3 randomized clinical trials in symptomatic knee osteoarthritis
AR Bihlet, I Byrjalsen, AC Bay-Jensen, JR Andersen, C Christiansen, ...
BMC musculoskeletal disorders 19 (1), 1-11, 2018
142018
A biomarker perspective on the acute effect of exercise with and without impact on joint tissue turnover: an exploratory randomized cross-over study
JJ Bjerre-Bastos, HB Nielsen, JR Andersen, M Karsdal, M Boesen, ...
European Journal of Applied Physiology 121 (10), 2799-2809, 2021
112021
The system can't perform the operation now. Try again later.
Articles 1–20